Expression Pattern of Neuronal Intermediate Filament α-internexin in Anterior Pituitary Gland and Related Tumors
Overview
Authors
Affiliations
Purpose: α-Internexin (INA) is a class IV neuronal intermediate filament protein that maintains the morphogenesis of neurons. It is expressed in developing neuroblasts and represents the major component of the cytoskeleton in cerebellar granule cells of adult central nervous system tissue. Data concerning INA expression in the human frontal pituitary lobe and related adenomas (PA) is missing.
Methods: Using immunohistochemistry we examined the distribution pattern of INA in a large cohort of 152 PA, 11 atypical PA, 4 pituitary carcinomas and 20 normal pituitaries (overall n = 187). Quantity of INA protein expression was semi-quantitatively evaluated and grouped into five categories (0 = 0%; 1 = >0-5%; 2 = >5-35%; 3 = >35-80%; 4 = >80% of cells).
Results: Cellular staining intensity of INA appeared significantly higher in gonadotropinomas (Go, n = 62), null cell adenomas (NC, n = 7) and thyrotropinomas (TSHomas, n = 7) compared to the other tumor subtypes (p ≤ 0.001). Furthermore, Go and NC showed a peculiar pseudorosette-like staining pattern surrounding blood vessels in 85.5% (59/69) of cases. Interestingly, areas exhibiting homogenous INA staining were often associated with oncocytic cell changes and decreased immunohistochemically detectable hormone expression. Only 8.5% (8/94) of other PA showed a comparable INA distribution (p ≤ 0.001).
Conclusion: Go, NC as well as TSHomas exhibit high levels of intracellular INA protein indicating neuronal transdifferentiation. A possible impact on pathogenesis and endocrine activity needs further investigation.
Targeting tumor innervation: premises, promises, and challenges.
Li X, Peng X, Yang S, Wei S, Fan Q, Liu J Cell Death Discov. 2022; 8(1):131.
PMID: 35338118 PMC: 8956600. DOI: 10.1038/s41420-022-00930-9.
Dlamini Z, Mathabe K, Padayachy L, Marima R, Evangelou G, Syrigos K Cancers (Basel). 2021; 13(9).
PMID: 33946706 PMC: 8125307. DOI: 10.3390/cancers13092138.
DNA Methylation Influences miRNA Expression in Gonadotroph Pituitary Tumors.
Boresowicz J, Kober P, Rusetska N, Maksymowicz M, Paziewska A, Dabrowska M Life (Basel). 2020; 10(5).
PMID: 32413978 PMC: 7281098. DOI: 10.3390/life10050059.
Progenitors from the central nervous system drive neurogenesis in cancer.
Mauffrey P, Tchitchek N, Barroca V, Bemelmans A, Firlej V, Allory Y Nature. 2019; 569(7758):672-678.
PMID: 31092925 DOI: 10.1038/s41586-019-1219-y.
Genetic aspects of pituitary carcinoma: A systematic review.
Yang Z, Zhang T, Gao H Medicine (Baltimore). 2016; 95(47):e5268.
PMID: 27893664 PMC: 5134857. DOI: 10.1097/MD.0000000000005268.